VISEN is an innovative biopharmaceutical company focused on endocrine diseases. We are dedicated to providing innovative therapies and compassionate, patient-centric care, because we believe that achieving better treatment processes and outcomes results in living better lives. Putting patients’ need first, VISEN is committed to providing first-in-class or best-in-class products and treatments for endocrine diseases. Our therapeutic areas cover endocrine diseases in adults and children, and rare endocrine diseases.
VISEN comprises seasoned professionals with multinational pharmaceutical experiences and leverages cutting-edge technologies and leading resources across the world. We are focused on the Chinese market, and have established offices in Shanghai, Beijing, Hong Kong and Taipei. We have also launched our Greater China R&D and manufacturing site in Suzhou to enhance R&D, manufacturing and commercialization efforts. Our goal is to enable Chinese endocrine patients to benefit from the world's most advanced and reliable treatment solutions earlier.
In 2018, VISEN Pharmaceuticals (VISEN) was formed by Ascendis Pharma A/S (Nasdaq: ASND) and an investor syndicate led by Vivo Capital (along with participation by Sofinnova Ventures), to develop and commercialize Ascendis Pharma’s endocrinology therapies in Greater China, which includes mainland China, Hong Kong, Macau, and Taiwan.
In Jan 2021, VISEN had closed a $150 million Series B financing led by Sequoia China with participation from OrbiMed, Sherpa Healthcare Partners, Cormorant, HBM Healthcare Investments, Pivotal bioVenture Partners China, Logos Capital, and CDG Capital, as well as all of the existing investors, including Ascendis Pharma A/S, Vivo Capital and Sofinnova Investments.
Company Details
- Employees
- 42
- Founded
- -
- Address
- 上海, Cn
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.visenpharma.com/
- Keywords
- 内分泌 and 创新医药.
- HQ
- 上海
Visen Pharmaceuticals Questions
Visen Pharmaceuticals's website is http://www.visenpharma.com/
Visen Pharmaceuticals's LinkedIn profile is https://cn.linkedin.com/company/%E7%BB%B4%E6%98%87%E8%8D%AF%E4%B8%9A%EF%BC%88%E4%B8%8A%E6%B5%B7%EF%BC%89%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8
Visen Pharmaceuticals has
42 employees.
View email and phone details for 42
employees at Visen Pharmaceuticals.
Visen Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Visen Pharmaceuticals's top competitors are
Oep Group 友華集團,
Rarestone Group,
Recbio,
Servier China,
Wanbang Biopharmaceuticals Co. Ltd,
Vivo Capital,
台灣維昇藥業有限公司 Visen Pharmaceuticals (Taiwan) Ltd.,
Innolake Biopharm,
Ascendis Pharma,
Sironax.
Visen Pharmaceuticals's categories are Pharmaceutical Manufacturing
Visen Pharmaceuticals's founding year is 2018
